Literature DB >> 31483863

From an assessment of multiple chelators, clodronate has potential for use in continuous chelation.

P P Wright1, C Cooper2, B Kahler1, L J Walsh1.   

Abstract

AIM: To identify chelators which when mixed with sodium hypochlorite (NaOCl) are stable, exhibiting minimal loss of free available chlorine (FAC) over 80 min and to further investigate potential mixtures by assessing FAC over 18 h and the capacity to remove smear layer.
METHODOLOGY: 0.25 mol L-1 EDTA (10%), 0.25 mol L-1 EGTA (egtazic acid), 0.25 mol L-1 CDTA (cyclohexanediaminetetraacetic acid), 0.25 mol L-1 DTPA (pentetic acid), 0.5 mol L-1 ATMP (aminotri(methylene phosphonic acid)) and 1 mol L-1 HPAA, (hydroxyphosphonoacetic acid), all at alkaline pH, were mixed equally with 5% NaOCl. 0.5 mol L-1 alkaline clodronate and 0.5 mol L-1 Na4 etidronate (15%) were mixed equally with 10% NaOCl. For all mixtures, the pH and temperature were measured over 80 min and additionally for the clodronate mixture over 18 h. Iodometric titration was used to measure the FAC of all mixtures except for HPAA. The following were compared with respect to their ability to remove smear layer: 1 mol L-1 clodronate + 10% NaOCl, 0.5 mol L-1 clodronate + 10% NaOCl, 1 mol L-1 etidronate + 10% NaOCl, 0.5 mol L-1 clodronate + 10% NaOCl and the sequences 5% NaOCl/17% EDTA/5% NaOCl and 5% NaOCl/17% EDTA. The area fraction occupied by open dentinal tubules as a percentage of the total area (% AF) from scanning electron microscopy micrographs was calculated using Image J. The results were statistically analysed with alpha set at 0.05.
RESULTS: Compared to its control, the mixture 0.5 mol L-1 clodronate + 10% NaOCl lost no FAC over 18 h (P > 0.05). The FAC of 0.25 mol L-1 CDTA mixed with 5% NaOCl fell to 96%, 92%, 75% and 4.9% at 20, 40, 60 and 80 min, respectively. Temperature rises were observed in all cases except in the etidronate and clodronate mixtures. Only in the clodronate mixture did the pH remain above pH 12 for the whole experiment. Although smear layer was removed, the % AF in 1 mol L-1 clodronate + 10% NaOCl, 0.5 mol L-1 clodronate + 10% NaOCl, 1 mol L-1 etidronate + 10% NaOCl was less than for 0.5 mol L-1 etidronate + 10% NaOCl and 5% NaOCl/17% EDTA/5% NaOCl and 5% NaOCl/17% EDTA.
CONCLUSION: Alkaline 0.5 mol L-1 clodronate mixed equally with 10% NaOCl has potential for use in continuous chelation, based on this assessment of stability and smear layer removal. Further research is needed to establish its efficacy and safety.
© 2019 International Endodontic Journal. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  clodronate; continuous chelation; etidronate; smear layer; sodium hypochlorite; stability

Mesh:

Substances:

Year:  2019        PMID: 31483863     DOI: 10.1111/iej.13213

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  4 in total

1.  Efficacy of EDTA and HEDP Chelators in the Removal of Mature Biofilm of Enterococcus faecalis by PUI and XPF File Activation.

Authors:  Alejandro Álvarez-Sagües; Nerea Herce; Ulises Amador; Francisco Llinares-Pinel; Estanislao Nistal-Villan; Jesús Presa; Laura Álvarez; Magdalena Azabal
Journal:  Dent J (Basel)       Date:  2021-04-09

2.  The response of dual-species bacterial biofilm to 2% and 5% NaOCl mixed with etidronic acid: A laboratory real-time evaluation using optical coherence tomography.

Authors:  Mariana Maciel Batista Borges; René J B Dijkstra; Flaviana Bombarda de Andrade; Marco Antonio Hungaro Duarte; Michel Versluis; Lucas W M van der Sluis; Xenos Petridis
Journal:  Int Endod J       Date:  2022-05-06       Impact factor: 5.165

Review 3.  Microbiological Aspects of Root Canal Infections and Disinfection Strategies: An Update Review on the Current Knowledge and Challenges.

Authors:  Jasmine Wong; Daniel Manoil; Peggy Näsman; Georgios N Belibasakis; Prasanna Neelakantan
Journal:  Front Oral Health       Date:  2021-06-25

Review 4.  Present status and future directions - irrigants and irrigation methods.

Authors:  Christos Boutsioukis; Maria Teresa Arias-Moliz
Journal:  Int Endod J       Date:  2022-04-06       Impact factor: 5.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.